- Biosimilar Marketing Application CMC Deficiencies identified in the US and in Europe
- Biosimilar developer, what are your BsUFA fees for FY 2019? Let’s clarify those for you!
- It’s NOT a Snowman, it’s SNOMED!
- FDA’s Thoughts on Adolescents in Adult Clinical Oncology Trials
- FDA releases Q&A Guidance After Confusion Surrounding S9A Nonclinical Evaluation for Anticancer Pharmaceuticals Guidance